Fig. 5From: Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort studyRisks of clinical events of rivaroxaban versus dabigatran in subgroups of group 2Back to article page